Worthy Stock Alerts (@WorthyStock) profile picture

#winning Equity Trade Alerts https://teapawt.org/t.co/eAQRirJKPS

Joined August 2019
Photo by Worthy Stock Alerts (@WorthyStock)Photo by Worthy Stock Alerts (@WorthyStock)Photo by Worthy Stock Alerts (@WorthyStock)Photo by Worthy Stock Alerts (@WorthyStock)Photo by Worthy Stock Alerts (@WorthyStock)Photo by Worthy Stock Alerts (@WorthyStock)Photo by Worthy Stock Alerts (@WorthyStock)Photo by Worthy Stock Alerts (@WorthyStock)Photo by Worthy Stock Alerts (@WorthyStock)Photo by Worthy Stock Alerts (@WorthyStock)
$ANT Anthropic is now oversubscribed by 7x, which means that investors have placed orders to buy 7x times more shares than Anthropic is making available in the offering.
🤖 Made with AI
1
5
1
18
1,631
ISM services at 10:00 ET
US Economic Calendar November 2-6 (ET zone) $SPY $QQQ $IWM
2
2
7
1,119
Worthy Stock Alerts retweeted
The election is over. All that fear priced into puts now comes out. When vol gets crushed, dealers buy back their hedges. That's support under NQ into the open. Key line is $QQQ $669 overnight lows which is also the 50 SMA on the weekly, Hold it and the squeeze has room. Lose it and the overnight low is back in play. $QQQ $NQ
7
2
30
11,722
Worthy Stock Alerts retweeted
$IQST - $IQSTEL 🌐 From scale to financial strength. 🔹Scale: US$450M annualized revenue run rate, July 2026. 🔹Profitability: planned majority stake in Ultranet, a profitable group. 🔹Financial strength: expected positive consolidated cash flow after closing. #LongTermInvesting
1
14
517
Worthy Stock Alerts retweeted
IQSTEL Inc. (NASDAQ: $IQST) is a global B2B telecommunications and digital distribution platform. Company Overview IQSTEL provides wholesale connectivity, voice, SMS/messaging, and related services to telecom operators and enterprises. It has relationships with ~600 of the world’s largest telecom operators, potentially reaching ~2.3 billion end users across ~24 countries. The core telecom business generates large top-line revenue with low gross margins (historically ~2–3%). The company is expanding into higher-margin digital services (fintech, AI telecom tools, cybersecurity, digital health, and content/microdrama via partnerships such as IDILIO TV). Key recent financial highlights: •1H 2026 revenue: $207 million (+59% YoY), annualized ~$414 million •July 2026 revenue: $37.5 million → ~$450 million annualized run rate •Stockholders’ equity (1H 2026): $17.2 million •Management targets significant EBITDA expansion and a path toward $1 billion in annual revenue (with Ultranet + organic/digital growth) Recent News •Oct 27, 2026 — Executives interview on path to $1B revenue, Ultranet acquisition, and high-margin digital services expansion.
 finance.yahoo.com/markets/st… •Oct 26, 2026 — Closed first tranche of up to $3 million in two-year senior secured non-convertible promissory notes (18% interest) + pre-funded warrants for 420,000 shares to fund the planned 51% acquisition of Ultranet Telecom Group (West African platform with ~$131 million 2025 revenue, profitable, $5 million EBITDA). Expected to make IQSTEL cash-flow positive on a consolidated basis and contribute meaningfully to adjusted EBITDA ($9 million annualized target from the deal). Share purchase agreement expected in November 2026; closing targeted mid-Q1 2027.
 prnewswire.com/news-releases… •Oct 8, 2026 — Advances microdrama commercialization; outreach to seven mobile operators serving ~93 million subscribers (part of broader digital content strategy via IDILIO TV / IQSTEL Digital). finance.yahoo.com/technology… Oct 1, 2026 — Edison Investment Research initiates coverage with a $6 per share valuation assessment. Forecasts positive adjusted EBITDA and free cash flow, $653 million 2027 revenue, and ~$12.5 million adjusted EBITDA (supported by Ultranet and higher-margin digital services). •Sep 22, 2026 — Reaches $450 million annualized revenue run rate based on July net revenue of $37.5 million. Supports full-year 2026 objective around $430 million.
 finance.yahoo.com/technology… Context The company emphasizes a “clean” capital structure (no convertibles in recent messaging) and is using non-dilutive-style debt for the Ultranet deal while highlighting per-share revenue metrics and the valuation gap versus book value and revenue scale. Growth is real on the top line, but profitability remains thin outside of the higher-margin digital initiatives and the pending Ultranet contribution. •Investor Relations: ir.iqstel.com •Investors landing page: landingpage.iqstel.com •Stock pages: stockanalysis.com/stocks/iqs…, stocktitan.net/overview/IQST
🤝 Paid partnership · 🤖 Made with AI
$IQST IQSTEL The Debt-Free and Hitting $400M Run Rate 5 Months Early: DD SUMMARY Q3 2025 Results • Revenue: $102.8 M (+42 % QoQ) • YTD: $232.8 M, on track for $340 M FY25, already at $400 M annualized run rate Balance Sheet • Zero debt • Zero convertibles • Zero warrants • $17.41 net assets per share $500 K stock dividend (CYCU shares) payable by Dec 31; shorts receive nothing 2026 Organic Guidance • Revenue: $430 M (+26 %) • EBITDA run rate: $15 M • Implied market cap: $150–300 M at 10-20× multiple 2027: $1 B revenue already secured Institutional Ownership • 12 institutions added 4 % stake in 120 days • Litchfield Hills Capital: $18 price target Business Highlights • Globetopper: cash-flow positive, scaling to $1 M EBITDA • AI-Cybersecurity Phase 1 live with Cycurion • IQ2Call.ai winning U.S. healthcare contracts Cleanest balance sheet + fastest growth + dividend + 10-20× upside IQST: the cheapest future-billion-dollar tech name on Nasdaq Next Catalysts 1. Q3 10-Q filing 2. Dividend record date 3. First tuck-in acquisition Chart | Financials | Full News | Not investment advice. Disclaimer link in bio. $PLTR $TSLA $NVDA $HOOD $AMD $RKLB $AMZN $GOOGL $APP $ALTS $ASTS $BTC $JPM $NFLX $SPY $SOL $ASST
3
10
6,821
US Economic Calendar November 2-6 (ET zone) $SPY $QQQ $IWM
US Economic Calendar October 26-30 (ET zone) $SPY $QQQ $IWM #FOMC #GDP #PCE
5
6
1
17
3,554
Hey @grok which company has the biggest absolute market-cap destruction from peak to trough in the history of public markets?
6
11
1
27
3,984
Hey @grok which stock in the S&P 500 has the largest discrepancy between current share price and the average analyst ratings?
7
14
68
24,424
Hey @grok if you had $1 million to invest today in only one stock and had to hold it for five years which stock would you buy. Only reply with the ticker.
67
16
1
129
352,916
Hey @grok Is it true that De Beers’ parent Anglo American is dumping diamonds to go all-in on copper?
6
11
34
4,973
Worthy Stock Alerts retweeted
About 40,000 people in the United States live with recurrent pericarditis. For the most stubborn cases, the therapies available today can help, but they often mean ongoing injections and a treatment that suppresses the immune system. Understanding those trade-offs is part of building something better for patients. #RecurrentPericarditis #CardiovascularDisease $CRDL
1
6
3
17
17,690
Geology IS beautiful. Fitzroy looks to have full news timeline in the horizon. Not advice. Disclosure: I hold options in this commodity. See further disclosures #GoCopper $FTZ.V $FTZFF
Geology is beautiful. Look at these textures from our infill drilling program. Happily there is an abundance of copper in the core, which is always a Good Thing to see in a copper project. In the next few weeks Fitzroy Minerals news flow will include the following: * Letter of Intent from Pucobre to highlight their appetite to a) claw-back 30% by paying 90% of historic investment in Buen Retiro (in Q2 2027) b) allow the Heap Leach project to use the Electro-Win plant at Planta Biocobre and c) provide input data for the PFS in the form of real costs and figures * Outline of Metallurgical test work / PFS update with commentary on the infill drill program * Geophysical results. Initially Mobile MT results from Caballos, and then later ANT (passive seismic by Fleet Space Technologies) at Buen Retiro * Drilling results from the Infill work, and the start of Exploration Drilling at Buen Retiro. [Remember we are advancing 2 parallel work streams at Buen Retiro - de-risking the near-term low-cost Heap Leach and, separately, the ongoing hunt for The Big Sulphide Orebody] $FTZ.V $FTZFF #GoCopper #GoExplorers #GoFitzroy
1
6
18
10,135
OTC will no longer require attorney letter for PINK current Status as of 01/31/25. Instead a Management Certification will be required…. What?! A management certification!? What does that entail and how long does it take? Even more concerning though, is will the management be able to pass certification?
8
4
20
2,337
My dividend has been transferred over and I’m excited for this company’s direct listing soon. @koilink koilink.com
$BBLC Blockchain Loyalty Corp. Reports Major Progress with Koilink Technologies and Attracts Interest from Leading Real Estate, Hospitality, and Gold Mining Companies Blockchain Loyalty Corp. (OTC: BBLC) also known as Belle Bonica Luxe Corp., is pleased to provide the following corporate updates on its subsidiary, Koilink Technologies Inc., as well as current developments within BBLC. Koilink Technologies Inc. Update: Koilink Technologies Inc., in which BBLC holds a 20% ownership stake, is nearing the final stages of its preparation to file with the Canadian Securities Exchange (CSE). Nearly all of the required documentation is being finalized, and we expect to submit the file to the CSE within the next few weeks. This marks a significant milestone for Koilink as it progresses towards a public listing. Additionally, Koilink has mandated Legacy Stock Transfer Inc., based in Addison, Texas, to serve as its official transfer agent. The company has also secured its CUSIP number, 50027R104, marking another step forward in the company's compliance and listing process. Exciting advancements for this company. Read more here. bellebonica.com/blog/2024/10… $NVDA $MSFT $LLY $TSM $WING $MCK $COST $NFLX $MU $AVGO $PINS $CMG $CRWD $QCOM $CL $AAPL $GOOG $AMZN $LULU $ELF $ROKU $AMD $GME $AMC $SIRI $FFIE $ZACK $TSLA $CRWD $SOUN $DJT $RUM
3
3
8
1,801
Rise and shine! Wishing you all a fantastic Thursday filled with opportunities and success. You've got this!
1
1
5
8
1,490
Don't miss @BlackBoxStocks's Black Friday and Cyber Monday sale! Get 32% off your purchase and enter to win the ultimate trading machine! Join Today -> staygreen.blackboxstocks.com… 🎯 Get the ultimate edge in trading: 💡 Dark Pool Insights 🔍 Scan the entire market for the most volatile stocks 📊 Institutional-Grade Charting 📚 Educational Resources to help you become a successful trader 🤝 A supportive community of like-minded traders $AAPL $ABBV $ADBE $AMZN $BYND $CRON $DIS $DISH $ELY $FDX $GME $GOOG $HD $INTC $IWM $JPM $LK $LOW $LULU $MA $NVDA $NFLX $QQQ $RH $ROKU $SNAP $SPY $TLT $T $TSLA $TVIX $UWT $UVXY $V $VXX $XOM
2
5
6
3,188
My goal is to reach $10k in donations in 2024. I’m so close, but the deadline is rapidly closing in. Please, if you have sufficient ability, consider a donation to my ‘Be the light” children’s foundation that helps support the oncology unit of the Alberta Children’s Hospital. Thank you so much for your support! ~Jennifer my.childrenshospital.ab.ca/f… #SuperEmerson #childhoodcancer @ACHFKids
3
8
2
34
9,295
$TGT #Earnings watch 👀 According to Zacks Investment Research, based on 15 analysts' forecasts, the consensus EPS forecast for the quarter is $2.29. The reported EPS for the same quarter last year was $2.1. $AAPL $ABBV $ADBE $AMAT $AMT $AMZN $BA $BABA $BYND $DIS $FDX $GOOG $HD $INTC $IWM $JPM $LK $LOW $LULU $LYFT $MA $MSFT $NVDA $NFLX $PINS $QQQ $RH $SNAP $SPY $TLT $T $TSLA $UWT $UVXY $V $VXX $XOM
2
5
4
3,534
$CRDL Here are the MAvERIC-Pilot study results that we’ve been waiting for! ❤️Marked and rapid reductions in both pericarditis pain and inflammation maintained throughout the 26-week study! ❤️Episodes of pericarditis per year substantially reduced ❤️MAvERIC-Pilot results support advancing CardiolRx™ into the Phase II/III MAVERIC-2
and the Phase III MAVERIC-3 clinical trials Congratulations to all long term shareholders! Read the full news release here~ finance.yahoo.com/news/cardi… $MRK $PFE $XLV $DRUG
$CRDL The day has arrived! Cardiol Therapeutics will announce important data tomorrow, November 18th at the American Heart Association annual “Scientific Sessions”. Details from their Phase II open-label MAvERIC-Pilot study investigating the impact of CardiolRx™ administered to patients with symptomatic recurrent pericarditis will be reported in an oral presentation as part of the Laennec Clinician-Educator Award & Lecture. Visit cardiolrx.com for information about how this company is addressing the illness with its promising FDA trial pipeline. $LLY $UNH $JNJ $ABBV $MRK $ABT $TMO $ISRG $AMGN $DHR $PFE $SYK $BSX
2
4
2
14
9,497